ProHance 279.3 mg/mL (Gadoteridol INJECTION, SOLUTION) 279.3 mg/mL

ProHance 279.3 mg/mL is a gadoteridol injection solution used for contrast enhancement in MRI scans. This single-dose vial is designed for intravenous administration, providing clear imaging for diagnostic purposes.

Strength

279.3 mg/mL

Pack Size

5 VIAL, SINGLE-DOSE in 1 BOX (0270-1111-04) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Bracco Diagnostics Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ProHance 279.3 mg/mL is primarily used as a contrast agent to enhance the visibility of internal structures during magnetic resonance imaging (MRI). It helps healthcare professionals obtain clearer images, which can be crucial for diagnosing various conditions. The gadoteridol in ProHance is designed to improve the contrast between normal and abnormal tissues, making it easier to identify abnormalities.

Side Effects

When administered intravenously, ProHance 279.3 mg/mL works by temporarily altering the magnetic properties of the tissues it comes into contact with. This alteration enhances the clarity of MRI images, allowing for better visualization of internal structures. The effects are typically short-lived, as the contrast agent is quickly excreted from the body.

Precautions & Warnings

ProHance 279.3 mg/mL should be handled with care, ensuring it is used only by trained healthcare professionals. It is important to check for any allergies or sensitivities to gadoteridol before administration. Proper storage and handling procedures should be followed to maintain the integrity of the solution.

Avoid Interactions

ProHance 279.3 mg/mL may interact with certain medications or conditions. It is important to inform healthcare providers about any existing medical conditions or ongoing treatments before using this contrast agent. Specific interactions with other contrast agents or medications should be discussed with a healthcare professional.

Frequently Asked Questions

ProHance 279.3 mg/mL is used as a contrast agent to enhance the visibility of internal structures during MRI scans.

ProHance 279.3 mg/mL is administered intravenously by a healthcare professional.

ProHance 279.3 mg/mL temporarily alters the magnetic properties of tissues to enhance MRI image clarity.

ProHance 279.3 mg/mL should be used by trained professionals, and allergies or sensitivities to gadoteridol should be checked.

ProHance 279.3 mg/mL may interact with certain medications or conditions, so it's important to consult a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.